Maternal cardiac disease: Update for the clinician

Obstetrics and Gynecology

Volumn 119, Issue 2 PART 1, 2012, Pages 345-359

  Simpson, Lynn L ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFAZOLIN; CEFTRIAXONE; CLINDAMYCIN; HEPARIN; ILOPROST; LOW MOLECULAR WEIGHT HEPARIN; PROSTACYCLIN; VANCOMYCIN; WARFARIN;

ANTICOAGULATION; AORTA DISEASE; AORTA DISSECTION; AORTA STENOSIS; ARTICLE; CARDIOMYOPATHY; CONGENITAL HEART DISEASE; COUNSELING; DILATED AORTOPATHY; ECHOCARDIOGRAPHY; ENDOCARDITIS; ENTEROCOCCAL INFECTION; FALLOT TETRALOGY; FEMALE; GREAT VESSELS TRANSPOSITION; HEART CATHETERIZATION; HEART DISEASE; HEART HEMODYNAMICS; HEART TRANSPLANTATION; HEART VALVE PROSTHESIS; HUMAN; INTRAPARTUM CARE; ISCHEMIC HEART DISEASE; LUNG VASCULAR RESISTANCE; MATERNAL CARE; MATERNAL DISEASE; MITRAL VALVE STENOSIS; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; PULMONARY HYPERTENSION;

FEMALE; HEART DEFECTS, CONGENITAL; HEART DISEASES; HUMANS; HYPERTENSION, PULMONARY; PATIENT CARE TEAM; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PRENATAL CARE;

EID: 84856483827     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318242e260     Document Type: Article

References (78)

1. Merz WM, Keyver-Pail MD, Baumgarten G, Lewalter T, Gembruch U. Spectrum of cardiovascular findings during pregnancy and parturition at a tertiary referral center. J Perinat Med 2011;39:251-6.
2. Kuklina EV, Callaghan WM. Chronic heart disease and severe obstetric morbidity among hospitalisations for pregnancy in the USA: 1995-2006. BJOG 2011;118:345-52.
3. Burlingame J, Horiuchi B, Ohana P, Onaka A, Sauvage LM. The contribution of heart disease to pregnancy-related mortality according to the pregnancy mortality surveillance system. J Perinatol 2011 Jun 9 [Epub ahead of print].
4. Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 2010;116:1302-9.
5. Thorne SA. Congenital heart disease: pregnancy in heart disease. Heart 2004;90:450-6.
6. Gelson E, Curry R, Gatzoulis MA, Swan L, Lupton M, Steer P, et al. Effect of maternal heart disease on fetal growth. Obstet Gynecol 2011;117:886-91.
7. Cardiac disease in pregnancy. ACOG Technical Bulletin No. 168-June 1992. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1993;41:298-306.
8. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104: 515-21. (Pubitemid 32738118)
9. Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003;24:761-81.
10. Foster E. The role of exercise testing for predicting pregnancy outcomes in women with congenital heart disease. Curr Cardiol Rep 2011;13:269-70.
11. Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007;49:2303-11. (Pubitemid 46891708)
12. Harris IS. Management of pregnancy in patients with congenital heart disease. Prog Cardiovasc Dis 2011;53:305-11.
13. Poppas A, Shroff SG, Korcarz CE, Hibbard JU, Berger DS, Lindheimer MD, et al. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation 1997;95:2407-15. (Pubitemid 27224736)
14. Tsiaras S, Poppas A. Cardiac disease in pregnancy: value of echocardiography. Curr Cardiol Rep 2010;12:250-6.
15. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(suppl):627S-44S. (Pubitemid 39297966)
16. Bowater SE, Thorne SA. Management of pregnancy in women with acquired and congenital heart disease. Postgrad Med J 2010;86:100-5.
17. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637-41.
18. Masamoto H, Uehara H, Mekaru K, Uezato T, Sakumoto K, Aoki Y. Warfarin-associated fetal intracranial hemorrhage in woman with mitral valve replacements: a case report. Am J Perinatol 2009;26:597-600.
19. Yinon Y, Siu SC, Warshafsky C, Maxwell C, McLeod A, Colman JM, et al. Use of low molecular weight heparin in pregnant women with mechanical heart valves. Am J Cardiol 2009;104:1259-63.
20. McLintock C. Anticoagulant therapy in pregnant women with mechanical prosthetic heart valves: no easy option. Thromb Res 2011;127(suppl 3):S56-60.
21. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benson HT, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med 2010;35:64-101.
22. Antibiotic prophylaxis for infective endocarditis. ACOG Committee Opinion No. 421. American College of Obstetricians and Gynecologists. Obstet Gynecol 2008;112:1193-4.
23. Wilson W, Taubert K, Gerwitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736-54.
24. Kuczkowski KM. Labor analgesia for the parturient with cardiac disease: what does an obstetrician need to know? Acta Obstet Gynecol Scand 2004;83:223-33. (Pubitemid 38338860)
25. Fernandes SM, Arendt KW, Landzberg MJ, Economy KE, Khairy P. Pregnant women with congenital heart disease: cardiac, anesthetic and obstetrical implications. Expert Rev Cardiovasc Ther 2010;8:439-48.
26. Hsu CH, Gomberg-Maitland, Glassner C, Chen JH. The management of pregnancy and pregnancy-related medical conditions in pulmonary arterial hypertension patients. Int J Clin Pract 2011;65(suppl 172):6-14.
27. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systemic overview from 1978 through 1996. J Am Coll Cardiol 1998;31:1650-7. (Pubitemid 28273311)
28. Bedard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J 2009;30:256-5.
29. Stewart R, Tuazon D, Olson G, Duarte AG. Pregnancy and primary pulmonary hypertension: successful outcome with epoprostenol therapy. Chest 2001;119:973-5. (Pubitemid 32197678)
30. Elliot CA, Stewart P, Webster VJ, Mills GH, Hutchinson SP, Howarth ES, et al. The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension. Eur Respir J 2005;26:168-73. (Pubitemid 40945946)
31. Dietz HC, Pyeritz RE, Hall BD, Cadle RG, Hamosh A, Schwartz J, et al. The Marfan syndrome locus: confirmation of assignment to chromosome 15 and identification of tightly linked markers at 15q15-q21.3. Genomics 1991;9:355-61.
32. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MC, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-148. (Pubitemid 44109952)
33. Lind J, Wallenburg HC. The Marfan syndrome and pregnancy: a retrospective study in a Dutch population. Eur J Obstet Gynecol Reprod Biol 2001;98:28-35. (Pubitemid 32758831)
34. Elefteriades JA. Indications for aortic replacement. J Thorac Cardiovasc Surg 2010;140(suppl):S5-9; discussion S45-51.
35. Pacini L, Digne F, Boumendil A, Muti C, Detaint D, Bioleau C, et al. Maternal complication of pregnancy in Marfan syndrome. Int J Cardiol 2009;136:156-61.
36. Siu SC, Colman JM. Heart disease and pregnancy. Heart 2001;85:710-5.
37. Silversides CK, Kiess M, Beauchesne L, Bradley T, Connelly M, Niwa K, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome. Can J Cardiol 2010;26:e80-97.
38. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006;355:788-98. (Pubitemid 44285584)
39. Gutman G, Baris HN, Hirsch R, Mandel D, Yaron Y, Lessing JB, et al. Loeys-Dietz syndrome in pregnancy: a case description and report of a novel mutation. Fetal Diagn Ther 2009; 26:35-7.
40. Erez Y, Ezra Y, Rojansky N. Ehlers-Danlos type IV in pregnancy. A case report and a literature review. Fetal Diagn Ther 2008;23:7-9. (Pubitemid 350249087)
41. Hammond R, Oligbo N. Ehlers Danlos Syndrome Type IV and pregnancy. Arch Gynecol Obstet 2011 May 3 [Epub ahead of print].
42. Stergiopoulos K, Shiang E, Bench T. Pregnancy in patients with pre-existing cardiomyopathies. J Am Coll Cardiol 2011; 58:337-50.
43. Gevaert S, Van Belleghem Y, Bouchez S, Herck I, De Somer F, De Block Y, et al. Acute and critically ill peripartum cardiomyopathy and 'bridge to' therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devices. Crit Care 2011;15:R93.
44. Krul SP, van der Smagt JJ, van den Berg MP, Sollie KM, Pieper PG, van Spaendonck-Zwarts KY. Systematic review of pregnancy in women with inherited cardiomyopathies. Eur J Heart Fail 2011;13:584-94.
45. Spirito P, Autore C. Management of hypertrophic cardiomyopathy. BMJ 2006;332:1251-5. (Pubitemid 44365417)
46. Autore C, Conte MR, Piccininno M, Bernabo P, Bonfiglio G, Bruzzi P, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:1864-9. (Pubitemid 35341967)
47. Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 2006;152:509-13. (Pubitemid 44233417)
48. Ntusi NB, Mayosi BM. Aetiology and risk factors of peripartum cardiomyopathy: a systemic review. Int J Cardiol 2009; 131:168-79.
49. Pyatt JR, Dubey G. Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments. Postgrad Med J 2011;87:34-9.
50. Elkayam U, Tummala PP, Rao K, Akhter MW, Karaalp IS, Wani OR, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344:1567-71. (Pubitemid 32479908)
51. Mandal D, Mandal S, Mukherjee D, Biswas SC, Maiti TK, Chattopadhaya N, et al. Pregnancy and subsequent pregnancy outcomes in peripartum cardiomyopathy. J Obstet Gynaecol Res 2011;37:222-7.
52. Ladner HE, Danielson B, Gilbert WM. Acute myocardial infarction in pregnancy and the puerperium: a populationbased study. Obster Gynecol 2005;105:480-4. (Pubitemid 40271209)
53. Salonen Ros H, Lichtenstein P, Bellocco R, Petersson G, Cnattingius S. Increased risks of circulatory diseases in late pregnancy and puerperium. Epidemiology 2001;12:456-60. (Pubitemid 32566488)
54. James AH, Jamison MG, Biswas MS, Brancazio LR, Swamy GK, Myers ER. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 2006;113: 1564-71. (Pubitemid 43739415)
55. Karadag B, Roffi M. Postpartal dissection of all coronary arteries in an in vitro-fertilized postmenopausal woman. Tex Heart Inst J 2009;36:168-70.
56. Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol 2008;52:171-80. (Pubitemid 351927266)
57. Kealey AJ. Coronary artery disease and myocardial infarction in pregnancy: a review of epidemiology, diagnosis, and medical and surgical management. Can J Cardiol 2010;26:185-9.
58. Hankins GD, Wendel GD, Leveno KJ, Stoneham J. Myocardial infarction during pregnancy: a review. Obstet Gynecol 1985;65:139-46. (Pubitemid 15187647)
59. Iadanza A, Del Pasqua A, Barbati R, Carrera A, Gentilini R, Favilli R, et al. Acute ST elevation myocardial infarction in pregnancy due to coronary vasospasm: a case report and review of literature. Int J Cardiol 2007;115:81-5. (Pubitemid 44855174)
60. Franklin WJ, Benton MK, Parekh DR. Cardiac disease in pregnancy. Tex Heart Inst J 2011;38:151-3.
61. John AS, Gurley F, Schaff HV, Warnes CA, Phillips SD, Arendt KW, et al. Cardiopulmonary bypass during pregnancy. Ann Thorac Surg 2011;91:1191-6.
62. van Mook WN, Peeters L. Severe cardiac disease in pregnancy, part II: impact of congenital and acquired cardiac diseases during pregnancy. Curr Opin Crit Care 2005;11: 435-48. (Pubitemid 41482699)
63. Davies GA, Herbert WN. Congenital heart disease in pregnancy. J Obstet Gynaecol Can 2007;29:409-14.
64. Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg MJ. Pregnancy outcomes in women with congenital heart disease. Circulation 2006;113:517-24.
65. Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJ, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010;31: 2124-32.
66. Balint OH, Siu SC, Mason J, Grewal J, Wald R, Oechslin EN, et al. Cardiac outcomes after pregnancy in women with congenital heart disease. Heart 2010;96:1656-61.
67. Goldmuntz E, Clark BJ, Mitchell LE, Jawad AF, Cuneo BF, Reed L, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 1998;32:492-8. (Pubitemid 28396502)
68. Perez-Delboy A, Simpson LL. Structural heart disease. In: Craigo SD, Baker ER, editors. Medical complications in pregnancy. New York (NY): McGraw-Hill; 2005. p. 501-25.
69. Veldtman GR, Connolly HM, Grogan M, Ammash NM, Warnes CA. Outcomes of pregnancy in women with tetralogy of Fallot. J Am Coll Cardiol 2004;44:174-80. (Pubitemid 38968478)
70. Balci A, Drenthen W, Mulder BJ, Roos-Hesselink JW, Voors AA, Vliegen HW, et al. Pregnancy in women with corrected tetralogy of Fallot: occurrence and predictors of adverse events. Am Heart J 2011;161:307-13.
71. Silversides CK, Salehian O, Oechslin E, Schwerzmann M, Vonder Muhll I, Khairy P, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenital cardiac lesions. Can J Cardiol 2010;26:e98-117.
72. Drenthen W, Pieper PG, Ploeg M, Voors AA, Roos-Hesselink JW, Mulder BJ, et al. Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries. Eur Heart J 2005;26:2588-95. (Pubitemid 41677312)
73. Canobbio MM, Morris CD, Graham TP, Landzberg MJ. Pregnancy outcomes after atrial repair for transposition of the great arteries. Am J Cardiol 2006;98:668-72. (Pubitemid 44233468)
74. Ploeg M, Drenthen W, van Dijk A, Pieper PG. Successful pregnancy after an arterial switch procedure for complete transposition of the great arteries. BJOG 2006;113:243-4.
75. Tobler D, Fernandes SM, Wald RM, Landzberg M, Salehian O, Siu SC, et al. Pregnancy outcomes in women with transposition of the great arteries and arterial switch operation. Am J Cardiol 2010;106:417-20.
76. Canobbio MM, Mair DD, van der Velde M, Koos BJ. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996;28:763-7. (Pubitemid 26288662)
77. Hoare JV, Radford D. Pregnancy after Fontan repair of complex congenital heart disease. Aust N Z J Obstet Gynaecol 2001;41:464-8. (Pubitemid 33100694)
78. Suchonska B, Borowiecka E, Szymusik I, Krzemien-Wiczynska S, Borowiecka-Elwertowska A. The course of pregnancy and delivery in a patient after a double-outlet right ventricle Fontan repair and the influence of this procedure on her general condition: report of a case. Surg Today 2008;38:853-6.